Trials / Conditions / Respiratory Distress Syndrome in Premature Infant

Respiratory Distress Syndrome in Premature Infant

42 registered clinical trials studyying Respiratory Distress Syndrome in Premature Infant — 12 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Optimising Breathing Support at Extubation in Very Preterm Infants: A Clinical Study NCT07251790	Murdoch Childrens Research Institute	N/A
Recruiting	Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting NCT07344714	Mayo Clinic	—
Not Yet Recruiting	Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration NCT07442669	Hackensack Meridian Health	N/A
Not Yet Recruiting	Speed of Lung Inflation During Ventilation of Extremely Preterm Infants NCT07101419	Murdoch Childrens Research Institute	N/A
Recruiting	Surfactant Therapy Via Supraglottic Airway to Preterm Neonates With RDS in Vietnam NCT07098910	Karolinska Institutet	N/A
Recruiting	Pragmatic Evaluation of Respiratory Distress Syndrome Treatment in Africa NCT06554522	Indiana University	Phase 4
Recruiting	Prophylactic Surfactant by Thin Endotracheal Catheter for Preterm Infants At Birth: the ProTeCt Trial NCT06557551	University College Dublin	N/A
Recruiting	Effect of Implementing Evidence Based Practices on Prevention of Associated Nasal Pressure Injuries Among Pret NCT06642285	Kafrelsheikh University	N/A
Recruiting	The NONA-LISA Trial NCT05609877	Rigshospitalet, Denmark	N/A
Completed	Recombinant Surfactant Protein D (rfhSP-D) to Prevent Neonatal Chronic Lung Disease NCT05898633	University College, London	Phase 1
Unknown	Safety and Efficacy of Intrapulmonary Percussive Ventilation in Preterm Infants NCT06229821	Augusta University	N/A
Recruiting	Physiologically Based Cord Clamping To Improve Neonatal Outcomes In Moderate And Late Preterm Newborns NCT06280872	Queen Fabiola Children's University Hospital	N/A
Unknown	REspiratory MEchanics for Delivering Individualised Exogenous Surfactant NCT05791331	Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico	N/A
Completed	Fast Assessment of Surfactant Deficiency in Preterm Infants to Speed up Treatment - Validation Study NCT05615428	Rigshospitalet, Denmark	—
Recruiting	30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants NCT03825835	University of Alberta	N/A
Terminated	PAL to Improve Oral Feeding for Infants With Chronic Lung Disease NCT05446389	University of Missouri-Columbia	N/A
Completed	Novel Low Cost Bubble CPAP as an Alternative Respiratory Support in Low Resource Setting NCT06082674	Ilocos Training and Regional Medical Center	Phase 2
Unknown	Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia. NCT04862377	Hospital Clinic of Barcelona	Phase 3
Recruiting	Effect of Nasal CPAP Versus NIPPV On Diaphragm Electrical Activity (Edi) In VLBW Preterm Infants NCT06295484	Sunnybrook Health Sciences Centre	N/A
Withdrawn	nHFOV Versus Invasive Conventional Ventilation for Preterm Neonates With Respiratory Distress Syndrome NCT04914715	Indus Hospital and Health Network	N/A
Completed	Effect of Chest Physiotherapy on the Development of Preterm Infants. NCT04689386	Universidad de Murcia	N/A
Completed	Neonatal Cardio-Pulmonary Outcome Measure NCT04324957	Asir John Samuel	—
Unknown	Combined Lung Ultrasounds and Transthoracic Electrical Bioimpedance in Preterm Infants With Respiratory Distre NCT04359134	IRCCS Azienda Ospedaliero-Universitaria di Bologna	—
Completed	A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact NCT03969992	Aerogen Pharma Limited	Phase 2
Unknown	Ventilator Weaning Outcome Between NIV-NAVA and Nasal CPAP (or IMV ) Modes in Premature Neonates NCT04118400	Taipei Medical University Hospital	—
Unknown	Budesonide With Intratracheal Surfactants in Extremely Preterm Infants NCT04019106	University of Manitoba	Phase 1 / Phase 2
Active Not Recruiting	Respiratory Effect of the LISA Method with Sedation by Propofol Versus Absence of Sedation. NCT04016246	University Hospital, Grenoble	Phase 3
Completed	Open Lung Strategy During Non-Invasive Respiratory Support of Very Preterm Infants in the Delivery Room NCT05031650	Dokuz Eylul University	N/A
Completed	Feasibility Study - Neofact NCT04086095	University Hospital Tuebingen	N/A
Unknown	Pressure HIgh or LOw DElivered to Preterm Newborns in the Delivery ROOM NCT06123845	ASST Fatebenefratelli Sacco	N/A
Terminated	Nasal High-frequency Jet Ventilation (nHFJV) Following Extubation in Preterm Infants NCT03558737	University of Utah	N/A
Completed	Physiological Changes With High-Flow Nasal Cannula NCT03700606	Sharp HealthCare	N/A
Unknown	Crossover Comparison of Tidal Volume Delivery During Nasal Intermittent Positive Pressure Ventilation in Prete NCT04326270	Arkansas Children's Hospital Research Institute	N/A
Completed	Enteral Nutrition Tolerance And REspiratory Support (ENTARES) NCT03548324	University of Turin, Italy	N/A
Unknown	Effect of Steroid Administration on Maternal Blood Levels of hLPCAT1 mRNA NCT03562182	Wayne State University	—
Completed	Risk Factors of Meconium Obstruction and Respiratory Distress Syndrome in Preterm Infants NCT03513640	Seoul National University Hospital	—
Completed	The Role of Circuit Flow During Mechanical Ventilation of Neonates NCT03306524	Cambridge University Hospitals NHS Foundation Trust	N/A
Completed	Immediate Treatment Outcomes of b-CPAP vs Oxygen Therapy in Preterm Babies Presenting With RDS at KCMC NCT03620448	Kilimanjaro Christian Medical Centre, Tanzania	N/A
Completed	Comparison of Two Nasal Interface for CPAP in Preterm NCT03212508	Dartmouth-Hitchcock Medical Center	—
Completed	Clinical RD (Respiratory Distress) Score for Objective Decision Making for Surfactant Therapy NCT03273764	Lady Hardinge Medical College	—
Completed	Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respirato NCT01941745	Tufts Medical Center	Phase 2
Completed	Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndro NCT01473264	Clarassance, Inc.	Phase 1 / Phase 2